The committee nominates a go for group for consideration. Best nominees are asked to submit an application which includes a explanation of promising research in need of funding. This application can be used as the basis for final judging.. ADDF establishes Goodes Prize to recognize scientists in Alzheimer’s medication discovery research Thanks to the generosity of ex – Warner-Lambert CEO and Chairman Melvin R. Goodes and his family members, the Alzheimer's Drug Discovery Basis has generated the just prize specifically recognizing researchers in Alzheimer's drug discovery study. Mr. He and his wife, Nancy, who’s also on the ADDF's Panel of Governors, are outspoken advocates for Alzheimer's research. ‘Mel Goodes' legacy is approximately taking bold possibilities,’ said Nancy Goodes.Cancer stem cells look like more resistant to radiotherapy and chemotherapy than the ‘bulk’ of the tumor and therefore, are often in charge of cancer relapse. As such, inhibiting residual leukemia stem cells from dividing is the key to obtain irreversible impairment of tumor development and long-term remission in sufferers. ‘Our recent studies determined the gene Brg1 as a regulator that governs the self-renewal, survival and proliferative capability of leukemia stem cells. As a result, targeting the Brg1 gene in leukemia stem cells may present new therapeutic opportunities by avoiding the disease from coming back’, Lessard concludes. Bloodstream.